Wealth Enhancement Advisory Services LLC Buys 393 Shares of American Healthcare REIT, Inc. $AHR

Wealth Enhancement Advisory Services LLC lifted its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 1.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,300 shares of the company’s stock after buying an additional 393 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in American Healthcare REIT were worth $1,086,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in AHR. Invesco Ltd. lifted its stake in shares of American Healthcare REIT by 1,543.1% in the first quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock valued at $152,180,000 after buying an additional 4,716,792 shares during the period. Alliancebernstein L.P. lifted its stake in shares of American Healthcare REIT by 350.7% in the first quarter. Alliancebernstein L.P. now owns 4,559,365 shares of the company’s stock valued at $138,149,000 after buying an additional 3,547,635 shares during the period. Vanguard Group Inc. lifted its stake in shares of American Healthcare REIT by 22.4% in the first quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock valued at $569,494,000 after buying an additional 3,437,861 shares during the period. Nuveen LLC bought a new stake in shares of American Healthcare REIT in the first quarter valued at about $68,097,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in American Healthcare REIT during the first quarter worth about $13,384,000. Institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

NYSE AHR opened at $41.92 on Thursday. The firm has a market cap of $7.07 billion, a price-to-earnings ratio of -190.52, a PEG ratio of 2.16 and a beta of 0.98. The company has a 50 day moving average of $41.30 and a 200-day moving average of $36.15. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. American Healthcare REIT, Inc. has a 1-year low of $23.66 and a 1-year high of $43.52.

American Healthcare REIT (NYSE:AHR) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.02. The business had revenue of $542.50 million during the quarter, compared to analyst estimates of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. American Healthcare REIT’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. On average, equities analysts forecast that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Tuesday, September 30th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.4%. American Healthcare REIT’s dividend payout ratio (DPR) is currently -454.55%.

Insider Buying and Selling at American Healthcare REIT

In related news, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the sale, the executive vice president owned 59,100 shares of the company’s stock, valued at $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.92% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Royal Bank Of Canada raised their price target on shares of American Healthcare REIT from $39.00 to $45.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Robert W. Baird assumed coverage on shares of American Healthcare REIT in a research note on Friday, July 18th. They set an “outperform” rating and a $41.00 price target for the company. JMP Securities raised their price target on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a “market outperform” rating in a research note on Monday, August 11th. Scotiabank restated an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Finally, Truist Financial raised their price target on shares of American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and ten have assigned a Buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $44.11.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.